Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68788-8752

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68788-8752). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Venlafaxine Fig1)

A scatter plot chart depicting fold changes and 90% confidence intervals for the pharmacokinetic parameters Cmax and AUC of venlafaxine under various special population conditions such as hepatic and renal impairment, CYP2D6 polymorphism, age over 60 years, and gender differences. The x-axis represents the change relative to the reference value, highlighting variations in drug exposure across different patient subgroups.*

FDA Label Image

Figure (Venlafaxine Fig2)

A scatter plot chart showing the fold change and 90% confidence intervals for venlafaxine and its O-desmethylvenlafaxine (ODV) metabolite concentrations (Cmax and AUC) when co-administered with various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole (CYP2D6 EM's and PM's), indinavir, metoprolol, imipramine, and lithium. The x-axis represents change relative to the reference value (range 0 to 3).*

FDA Label Image

Figure (Venlafaxine Fig3)

A scatter plot chart displaying the fold change and 90% confidence intervals of various pharmacokinetic parameters (Cmax and AUC) for different interacting drugs and analytes relative to a reference value. The chart compares drugs such as Ethanol, Diazepam, Alprazolam, Indinavir, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium, indicating their effect on drug concentrations with points plotted along a horizontal axis representing fold change.*

FDA Label Image

Venlafaxine HCl Extended-release Capsules Usp 150mg (Venlafaxine Fig8)

Label for Venlafaxine HCl Extended-Release Capsules USP 150 mg by Preferred Pharmaceuticals Inc. and manufactured by Aurobindo Pharma Limited. The label indicates it is a generic for Effexor ER and includes storage instructions, a barcode, and bilingual dosage directions in English and Spanish. Several fields for lot number, batch, and expiration date are blank.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride, showing its molecular configuration including a cyclohexane ring, methoxybenzene ring, and dimethylamino group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.